ID

44719

Beschrijving

see http://clinicaltrials.gov/ct2/show/record/NCT00617669 Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Link

http://clinicaltrials.gov/ct2/show/record/NCT00617669

Trefwoorden

  1. 15-11-11 15-11-11 -
  2. 23-03-14 23-03-14 - Martin Dugas
  3. 10-08-14 10-08-14 - Martin Dugas
  4. 13-04-21 13-04-21 - Dr. rer. medic Philipp Neuhaus
  5. 20-09-21 20-09-21 -
  6. 28-09-21 28-09-21 - Sarah Riepenhausen
Houder van rechten

AstraZeneca

Geüploaded op

28 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility DRKS00005404 NCT00617669 Prostate Cancer

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Beschrijving

Age

Datatype

integer

Maateenheden
  • years
Alias
UMLS CUI-1
C0001779
years
male
Beschrijving

Gender Male

Datatype

boolean

Alias
UMLS CUI-1
C0086582
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
Beschrijving

Prostate Cancer with bone metastasis

Datatype

boolean

Alias
UMLS CUI-1
C0600139
UMLS CUI-2
C0153690
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Beschrijving

PSA increase

Datatype

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Beschrijving

Castration

Datatype

boolean

Alias
UMLS CUI-1
C0007347
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Beschrijving

Previous chemotherapy

Datatype

boolean

Alias
UMLS CUI-1
C0205156
UMLS CUI-2
C0392920
Suffering from heart failure or had a myocardial infarction within last 6 months
Beschrijving

Heart disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0155626
A history of epilepsy or seizures
Beschrijving

Epilepsy, seizures

Datatype

boolean

Alias
UMLS CUI-1
C0014544
UMLS CUI-2
C0036572

Similar models

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
integer
C0001779 (UMLS CUI-1)
Gender Male
Item
male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer with bone metastasis
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
boolean
C0600139 (UMLS CUI-1)
C0153690 (UMLS CUI-2)
PSA increase
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C0205156 (UMLS CUI-1)
C0392920 (UMLS CUI-2)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018801 (UMLS CUI [1,1])
C0155626 (UMLS CUI [1,2])
Epilepsy, seizures
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)
C0036572 (UMLS CUI-2)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial